Alkem Lab

ALKEM26 Apr 2024

Pharmaceuticals

₹

+42.75 (+0.88%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Alkem Lab

Alkem Lab

Pharmaceuticals

ALKEM26 Apr 2024

₹

+42.75 (+0.88%)

OverviewFundamentalsFutures Options

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
09-Feb-2024	D	Interim dividend declared of Rs. 35 per share and pay out on and from 1st March	16-Feb-2024
19-May-2023	D	The Board of Directors at its meeting held today i.e. 19th May, 2023, has, inter alia: 1. recommended a final dividend of Rs. 10/- (Rupees Ten only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2023, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. 2. fixed that the 49th Annual General Meeting of the Company shall be held on 25th August, 2023 and the cut-off date for the purpose of the said Annual General Meeting has been fixed as 18th August, 2023. 3. fixed 10th August, 2023 as the record date for the purpose of payment of final dividend. The dividend, if declared by the shareholders, shall be paid on and from 30th August, 2023. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.30 p.m. Kindly take the same on record.	10-Aug-2023
10-Feb-2023	D	The Board of Directors of the Company, at its meeting held today, i.e. 10th February, 2023 have inter alia: Interim Dividend of Rs. 15/- (Rupees Fifteen only) per equity share having a face value of Rs. 2/- per share. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 01.10 p.m. Kindly take the same on record.	17-Feb-2023
10-Feb-2023	D	The Board of Directors of the Company, at its meeting held today, i.e. 10th February, 2023 have inter alia: Special Dividend of Rs. 25/- (Rupees Twenty-Five only) per equity share having a face value of Rs. 2/- per share.	17-Feb-2023
13-May-2022	D	The Board of Directors at its meeting held today i.e. 13th May, 2022, has, inter alia: 1. recommended a final dividend of Rs. 4/- per equity share of Rs. 2/- each for the financial year ended 31st March, 2022, for the approval of the shareholders of the Company at the ensuing Annual General Meeting.	08-Aug-2022
04-Feb-2022	D	The Board of Directors of the Company, at its meeting held today, i.e. 04th February, 2022 have inter alia: Declared Interim Dividend of Rs 30/- (Rupees Thirty only) per equity share on the face value of Rs. 2/- per share for the financial year 2021-22 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations.	10-Feb-2022
25-May-2021	D	Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2021, inter alia, has recommended a final dividend of Rs. 5/- (Rupees Five only) per equity share of Rs. 2/- each for the financial year ended March 31, 2021, for the approval of the shareholders of the Company at the ensuing Annual General Meeting.	09-Aug-2021
05-Feb-2021	D	Pursuant to Reg 30 read with Reg 33 and Reg 42 of the SEBI (LODR) Regulations, 2015 , the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia: a. Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st Dec, 2020. b. Declared Interim Dividend of Rs. 25/- (Rupees Twenty Five only) per equity share on the face value of Rs. 2/- per share for the financial year 2020-21 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. c. Approved the alteration of the Memorandum of Association ('MOA') of the Company, by adding certain clauses under Part B of Clause III of MOA and carrying out suitable modifications in the line with the provisions of the Companies Act, 2013, subject to the approval of the shareholders of the Company through Postal Ballot. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.45 p.m.	11-Feb-2021
05-Jun-2020	D	The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia: recommended a final dividend of Rs. 3/- (Rupees three only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2020, for the approval of the shareholders of the Company at the ensuing Annual General Meeting.	10-Aug-2020
07-Feb-2020	D	Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company, at its meeting held on February 07, 2020, inter alia, has declared Interim Dividend of Rs. 22/- (Rupees Twenty Two only) per equity share on the face value of Rs. 2/- per share for the financial year 2019-20. The date of payment of Interim Dividend shall be on and from February 18, 2020.	13-Feb-2020
30-May-2019	D	The Board of Directors at its meeting held today i.e. 30th May, 2019 has recommended a final dividend of Rs. 8/- (Rupees Eight only) per equity share of Rs. 2/- each for the financial year ended 3l't March, 2019, for the approval of the shareholders of the Company at the ensuing Annual General Meeting.	19-Aug-2019
08-Feb-2019	D	In continuation of our letter dated 1st February, 2019, the Board of Directors of the Company, at its meeting held today, i.e. 8th February, 2019 inter alia, has declared Interim Dividend of Rs. 8/- (Rupees Eight only) per equity share on the face value of Rs. 2/- per share for the financial year 2018-19 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. The date of payment of Interim Dividend shall be on and from 21st February, 2019.Further, as informed vide our letter dated 1st February, 2019 submitted to the Stock Exchanges pursuant to Clause 42 of the Listing Regulations, the record date for the purpose of payment of interim dividend for the financial year 2018-19 would be Monday, 18th February, 2019. Kindly take the same on record.	15-Feb-2019
30-May-2018	D	The Board of Directors at its meeting held today i.e. 30th May, 2018, has, inter alia 1. recommended a final dividend of Rs. 7/- (Rupees Seven only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2018, for the approval of the shareholders of the Company at the ensuing Annual General Meeting.	23-Aug-2018
09-Feb-2018	D	Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2018, inter alia, have declared Interim Dividend of Rs. 6/- (Rupees Six only) per equity share on the face value of Rs. 2/- per share for the financial year 2017-18. The date of payment of Interim Dividend shall be on and from February 23, 2018.	16-Feb-2018
26-May-2017	D	Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2017, inter alia, has recommended a final dividend of Rs. 9.00/- (Rupees Nine only) per equity share of Rs. 2/- each for the financial year ended March 31, 2017, for the approval of the shareholders of the Company at the ensuing Annual General Meeting.	31-Aug-2017
11-Nov-2016	D	Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 11, 2016, have declared Interim Dividend of Rs. 6/-per equity share on the face value of Rs. 2/- per share for the financial year 2016-17. The date of payment of Interim dividend shall be on & From November 28, 2016.	23-Nov-2016
09-Mar-2016	D	Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 09, 2016, has declared second Interim Dividend of Rs. 9.7/- per equity share on the face value of Rs. 2/- per share for the financial year 2015-16. The date of payment of Interim Dividend shall be on & from March 23, 2016. The above said meeting of Board of Directors commenced at 11:00 A.M. and concluded at 1.00 P.M.	18-Mar-2016
09-Feb-2024	BC	The Company has fixed 23rd Feb as cut off date. In furtherance to our intimation dated 09th February, 2024 and pursuant to the applicable provisions of the Companies Act, 2013 and SEBI (LODR) Regu	05-Apr-2024
09-Feb-2024	BC	Interim dividend declared of Rs. 35 per share and pay out on and from 1st March	31-Mar-2024
01-Apr-2024	BC	Dhananjay and Madhurima Singh Trust	28-Mar-2024
01-Apr-2024	BC	Madhurima Singh	28-Mar-2024
01-Feb-2024	BC	Interim Dividend Interim dividend declared of Rs. 35 per share and pay out on and from 1st March (As Per BSE Announcement dated on 09.02.2024)	17-Feb-2024

Announcement Date09-Feb-2024

Ex Dividend Date16-Feb-2024

Dividend(%)1750

Announcement Date19-May-2023

Ex Dividend Date10-Aug-2023

Dividend(%)500

Announcement Date10-Feb-2023

Ex Dividend Date17-Feb-2023

Dividend(%)750

Announcement Date10-Feb-2023

Ex Dividend Date17-Feb-2023

Dividend(%)1250

Announcement Date13-May-2022

Ex Dividend Date08-Aug-2022

Dividend(%)200

Announcement Date04-Feb-2022

Ex Dividend Date10-Feb-2022

Dividend(%)1500

Announcement Date25-May-2021

Ex Dividend Date09-Aug-2021

Dividend(%)250

Announcement Date05-Feb-2021

Ex Dividend Date11-Feb-2021

Dividend(%)1250

Announcement Date05-Jun-2020

Ex Dividend Date10-Aug-2020

Dividend(%)150

Announcement Date07-Feb-2020

Ex Dividend Date13-Feb-2020

Dividend(%)1100

Announcement Date30-May-2019

Ex Dividend Date19-Aug-2019

Dividend(%)400

Announcement Date08-Feb-2019

Ex Dividend Date15-Feb-2019

Dividend(%)400

Announcement Date30-May-2018

Ex Dividend Date23-Aug-2018

Dividend(%)350

Announcement Date09-Feb-2018

Ex Dividend Date16-Feb-2018

Dividend(%)300

Announcement Date26-May-2017

Ex Dividend Date31-Aug-2017

Dividend(%)450

Announcement Date11-Nov-2016

Ex Dividend Date23-Nov-2016

Dividend(%)300

Announcement Date09-Mar-2016

Ex Dividend Date18-Mar-2016

Dividend(%)485

No Rights has been declared by ALKEM

Book Closure

Record Date	Split Date	Purpose
05-Apr-2024	01 Jan'1900	The Company has fixed 23rd Feb as cut off date. In furtherance to our intimation dated 09th February, 2024 and pursuant to the applicable provisions of the Companies Act, 2013 and SEBI (LODR) Regu
31-Mar-2024	-	Interim dividend declared of Rs. 35 per share and pay out on and from 1st March
28-Mar-2024	-	Dhananjay and Madhurima Singh Trust
28-Mar-2024	-	Madhurima Singh
17-Feb-2024	-	Interim Dividend Interim dividend declared of Rs. 35 per share and pay out on and from 1st March (As Per BSE Announcement dated on 09.02.2024)

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Alkem Laboratories Ltd ₹4,910.40(+42.75/0.88%)	4,910.40	+42.75	58,711.20	43.29	34.08	5.78
Lupin Ltd ₹1,615.95(+21.55/1.35%)	1,615.95	+21.55	73,646.94	128.34	35.73	3.82
Ipca Laboratories Ltd ₹1,338.50(+10.05/0.76%)	1,338.50	+10.05	33,958.31	90.83	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,865.05(+2.25/0.12%)	1,865.05	+2.25	28,944.61	77.48	57.14	10.78
Sanofi India Ltd ₹8,274.15(+120.75/1.48%)	8,274.15	+120.75	19,055.37	38.57	32.28	18.77
IOL Chemicals & Pharmaceuticals Ltd ₹399.50(-0.85/-0.21%)	399.50	-0.85	2,345.28	-2.77	13.60	1.48

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	2494.59	2634.59	2253.17	2237.99	2296.72	2461.49
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2494.59	2634.59	2253.17	2237.99	2296.72	2461.49
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	95.66	61.84	64.70	76.60	60.74	73.64
Total Income	2590.25	2696.43	2317.87	2314.59	2357.46	2535.13
Total Expenditure	1976.64	1979.99	1919.42	1906.00	1840.75	2055.81
PBIDT	613.61	716.44	398.45	408.59	516.71	479.32
Interest	21.11	18.70	21.42	21.74	22.62	20.02
PBDT	592.50	697.74	377.03	386.85	494.09	459.30
Depreciation	58.12	59.02	58.11	57.16	58.14	57.74
Tax	90.46	111.48	53.93	53.63	76.40	69.98
Deferred Tax	-60.31	-119.27	-6.45	21.27	-29.34	-19.11
Reported Profit After Tax	504.23	646.51	271.44	254.79	388.89	350.69
Extra-ordinary Items	-42.62	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	546.85	646.51	271.44	254.79	388.89	350.69

EPS (Unit Curr.)	42.17	54.07	22.70	21.31	32.53	29.33
EPS (Adj) (Unit Curr.)	42.17	54.07	22.70	21.31	32.53	29.33
Calculated EPS (Unit Curr.)	42.18	54.08	22.71	21.31	32.53	29.33
Calculated EPS (Adj) (Unit Curr.)	42.18	54.08	22.71	21.31	32.53	29.33
Calculated EPS (Ann.) (Unit Curr.)	168.71	216.31	90.82	85.25	130.12	117.34
Calculated EPS (Adj) (Ann.) (Unit Curr.)	168.71	216.31	90.82	85.25	130.12	117.34
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	1750.00	0.00	0.00	0.00	2000.00	0.00
Equity	23.91	23.91	23.91	23.91	23.91	23.91
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.60	27.19	17.68	18.26	22.50	19.47
PBDTM(%)	23.75	26.48	16.73	17.29	21.51	18.66
PATM(%)	20.21	24.54	12.05	11.38	16.93	14.25

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	3323.87	3440.17	2967.72	2902.60	3040.91	3079.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	3323.87	3440.17	2967.72	2902.60	3040.91	3079.37
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	93.64	63.19	65.84	68.67	45.33	50.67
Total Income	3417.51	3503.36	3033.56	2971.27	3086.24	3130.04
Total Expenditure	2667.59	2751.10	2578.53	2652.33	2441.86	2625.46
PBIDT	749.92	752.26	455.03	318.94	644.38	504.58
Interest	25.46	30.32	29.77	28.96	27.05	24.85
PBDT	724.46	721.94	425.26	289.98	617.33	479.73
Depreciation	69.56	73.90	72.41	78.32	78.44	77.40
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	113.60	159.05	65.78	62.86	89.14	86.98
Deferred Tax	-62.98	-125.90	-0.74	81.12	-10.21	-32.37
Reported Profit After Tax	604.28	614.89	287.81	67.68	459.96	347.72
Minority Interest After NP	9.32	-5.63	1.08	-3.30	5.25	16.88
Net Profit after Minority Interest	594.96	620.52	286.73	70.98	454.71	330.84

Extra-ordinary Items	-42.41	-43.51	0.00	-32.93	0.00	0.00
Adjusted Profit After Extra-ordinary item	637.37	664.03	286.73	103.91	454.71	330.84

EPS (Unit Curr.)	49.76	51.90	23.98	5.94	38.03	27.67
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	1750.00	0.00	0.00	0.00	2000.00	0.00
Equity	23.91	23.91	23.91	23.91	23.91	23.91

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.56	21.87	15.33	10.99	21.19	16.39
PBDTM(%)	21.80	20.99	14.33	9.99	20.30	15.58
PATM(%)	18.18	17.87	9.70	2.33	15.13	11.29

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	23.91	23.91	23.91	23.91	23.91	23.91
Reserves Total	9325.94	8719.75	7601.84	6256.53	5441.30	4861.45
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	9349.85	8743.66	7625.75	6280.44	5465.21	4885.36
Secured Loans	119.31	1010.07	327.88	238.60	32.38	110.71
Unsecured Loans	1062.38	1283.71	1055.63	970.78	470.58	436.81
Total Debt	1181.69	2293.78	1383.51	1209.38	502.96	547.52
Total Liabilities	10531.54	11037.44	9009.26	7489.82	5968.17	5432.88
APPLICATION OF FUNDS :
Gross Block	2932.25	2826.98	2481.89	2351.73	1973.17	1713.69
Less : Accumulated Depreciation	1107.16	944.91	723.53	514.97	366.79	242.70
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1825.09	1882.07	1758.36	1836.76	1606.38	1470.99
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	228.75	232.45	323.26	313.66	381.59	298.92
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3005.55	2528.61	2152.38	1956.04	1695.60	1544.50
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1724.66	1975.73	1513.26	1092.58	991.28	1024.16
Sundry Debtors	1768.34	1768.22	1556.55	1555.07	966.64	875.00
Cash and Bank	2163.87	2297.21	1673.36	765.61	397.94	278.30
Loans and Advances	802.75	684.29	726.20	654.40	505.64	513.15
Total Current Assets	6459.62	6725.45	5469.37	4067.66	2861.50	2690.61
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1683.76	1673.80	1367.46	1207.97	1041.45	1143.03
Provisions	224.44	194.02	198.66	168.73	131.78	102.46
Total Current Liabilities	1908.20	1867.82	1566.12	1376.70	1173.23	1245.49
Net Current Assets	4551.42	4857.63	3903.25	2690.96	1688.27	1445.12
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1292.75	1248.66	1143.51	1005.92	835.63	759.87
Deferred Tax Liability	207.83	199.92	189.08	186.76	199.04	181.82
Net Deferred Tax	1084.92	1048.74	954.43	819.16	636.59	578.05
Total Assets	10695.73	10549.50	9091.68	7616.58	6008.43	5337.58
Contingent Liabilities	289.53	274.92	287.75	278.73	329.43	277.30

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	23.91	23.91	23.91	23.91	23.91	23.91
Reserves Total	9021.38	8613.99	7352.82	6136.76	5415.43	4839.86
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	9045.29	8637.90	7376.73	6160.67	5439.34	4863.77
Minority Interest	389.71	209.43	181.28	148.30	132.61	121.55
Secured Loans	300.57	1335.32	686.30	634.43	459.27	552.14
Unsecured Loans	1096.11	1332.87	1105.68	981.09	484.80	445.42
Total Debt	1396.68	2668.19	1791.98	1615.52	944.07	997.56
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	544.17	340.67	259.56	318.08	187.11	164.60
Total Liabilities	11375.85	11856.19	9609.55	8242.57	6703.13	6147.48
APPLICATION OF FUNDS :
Gross Block	4050.25	4185.60	3768.85	3606.95	3026.09	2603.78
Less: Accumulated Depreciation	1367.42	1283.87	975.87	698.94	495.65	320.19
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2682.83	2901.73	2792.98	2908.01	2530.44	2283.59
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	323.24	339.48	393.28	362.97	492.96	380.97
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	621.82	370.98	332.78	261.39	323.62	444.27
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	2607.53	3005.53	2312.44	1818.82	1499.87	1442.19
Sundry Debtors	2132.18	1884.60	1607.21	1649.36	1248.41	1080.50
Cash and Bank	2616.89	2578.58	1990.45	1092.21	661.60	576.78
Loans and Advances	1055.89	827.41	834.34	775.37	578.37	567.93
Total Current Assets	8412.49	8296.12	6744.44	5335.76	3988.25	3667.40
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1984.61	1923.08	1654.14	1471.42	1348.83	1375.19
Provisions	396.19	289.92	255.57	231.55	155.93	141.29
Total Current Liabilities	2380.80	2213.00	1909.71	1702.97	1504.76	1516.48
Net Current Assets	6031.69	6083.12	4834.73	3632.79	2483.49	2150.92
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1498.30	1527.92	1281.97	1099.99	1066.13	965.33
Deferred Tax Liability	195.80	218.66	174.06	167.42	358.80	311.39
Net Deferred Tax	1302.50	1309.26	1107.91	932.57	707.33	653.94
Other Assets	413.77	851.62	147.87	144.84	165.29	233.79
Total Assets
Contingent Liabilities	323.79	307.47	296.33	280.91	330.58	276.75

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	81.82	15.22	20.69	161.44	5.16
Net Cash from Operating Activities	1437.42	1299.34	1324.48	681.78	745.09
Net Cash Used In Investing Activities	197.04	-1669.33	-1120.99	-995.17	-313.06
Net Cash Used In Financing Activities	-1711.27	436.59	-208.96	172.64	-275.75
Net Inc./Dec In Cash And Cash Equivalents	-76.81	66.60	-5.47	-140.75	156.28
Cash And Cash Equivalents At End Of The Year	5.01	81.82	15.22	20.69	161.44

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

56.74%

FII Shareholding

9.11%

DII Shareholding

15.63%

Public Shareholding

18.52%

**Promoter pledged shareholding 56.74%

About Alkem Laboratories Ltd

Alkem Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 58604.78 crores. It has reported a sales of Rs. 2494.59 crores and a net profit of Rs. 504.23 crores for the quarter ended December 2018. The company management includes Basudeo N Singh, Basudeo N Singh,SANDEEP SINGH,Mritunjay Kumar Singh,A K Purwar,SANGEETA KAPILJIT SINGH,SUDHA RAVI,Manish Narang,Dheeraj Sharma,Narendra Aneja,SARVESH SINGH,Madhurima Singh,Sujjain Talwar,Srinivas Singh (Alkem Laboratories Ltd) among others.

Chairman

Basudeo N Singh

Registered office

Alkem House SenapatiBapat Marg,Lower Parel,Mumbai,Maharashtra,400013

FAX :91-22-24952955

Background

Incorporation Year1973

Face Value₹2

Market Lot1

How to buy Alkem Lab shares on nse?

To buy Alkem Lab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Alkem Lab share price today?

The Alkem Lab shares price on nse is Rs.4910.4 today.

What is the market cap of Alkem Lab shares on NSE ?

The company has a market capitalization of Rs.58711.20Cr

What is the PE & PB ratio of Alkem Lab shares ?

PE is 34.08 and PB is 5.78

What is the 52 Week High and Low of Alkem Lab shares?

Alkem Lab stock price high: Rs.5520 Alkem Lab stock price low: Rs.3186.3

How can I purchase Alkem Laboratories stock?

You can conveniently buy Alkem Laboratories stock through a reputed brokerage like Motilal Oswal. You will have to open a demat account linked with a trading account and then you can purchase the stock through an exchange via Motilal Oswal.

Is Alkem overvalued?

Alkem Laboratories is one of the companies which is fairly valued at present. It stands in the category of companies which show positive trends in their quarterly results. Additionally, the company’s fundamentals may be considered average to good.

What is the dividend that Alkem declared?

The last dividend paid by Alkem Laboratories was on 17 February 2023, at Rs. 15 per share, which was an interim dividend. A special dividend was also paid on the same date, amounting to Rs. 25 per share.